Cargando…

Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease

The prevalence of metabolism-associated fatty liver disease (MAFLD) represents an urgent pandemic, complicated by a higher risk of morbidity and mortality as well as an increased socio-economic burden. There is growing evidence proving the impact of gut microbiota modifications on the development an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellanti, Francesco, Lo Buglio, Aurelio, Vendemiale, Gianluigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057853/ https://www.ncbi.nlm.nih.gov/pubmed/36984762 http://dx.doi.org/10.3390/metabo13030322

Ejemplares similares

Muscle Delivery of Mitochondria-Targeted Drugs for the Treatment of Sarcopenia: Rationale and Perspectives
por: Bellanti, Francesco, et al.
Publicado: (2022)

Redox Homeostasis and Immune Alterations in Coronavirus Disease-19
por: Bellanti, Francesco, et al.
Publicado: (2022)

Mitochondrial Impairment in Sarcopenia
por: Bellanti, Francesco, et al.
Publicado: (2021)

The Mediterranean Diet Slows Down the Progression of Aging and Helps to Prevent the Onset of Frailty: A Narrative Review
por: Capurso, Cristiano, et al.
Publicado: (2019)

Malnutrition in Hospitalized Old Patients: Screening and Diagnosis, Clinical Outcomes, and Management
por: Bellanti, Francesco, et al.
Publicado: (2022)

Controlling Nutritional Status (CONUT) Score as a Predictive Marker in Hospitalized Frail Elderly Patients
por: Lo Buglio, Aurelio, et al.
Publicado: (2023)

Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Coronavirus disease 2019 and non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2021)

Adherence to Mediterranean Diet, Malnutrition, Length of Stay and Mortality in Elderly Patients Hospitalized in Internal Medicine Wards
por: Lo Buglio, Aurelio, et al.
Publicado: (2019)

Sarcopenia Is Associated with Changes in Circulating Markers of Antioxidant/Oxidant Balance and Innate Immune Response
por: Bellanti, Francesco, et al.
Publicado: (2023)

Factors Related to Nurses’ Burnout during the First Wave of Coronavirus Disease-19 in a University Hospital in Italy
por: Bellanti, Francesco, et al.
Publicado: (2021)

Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2022)

Controlling Nutritional Status Score as a Predictor for Chronic Obstructive Pulmonary Disease Exacerbation Risk in Elderly Patients
por: Lo Buglio, Aurelio, et al.
Publicado: (2023)

Impact of senescence on the transdifferentiation process of human hepatic progenitor-like cells
por: Bellanti, Francesco, et al.
Publicado: (2021)

Comparison of Three Nutritional Screening Tools with the New Glim Criteria for Malnutrition and Association with Sarcopenia in Hospitalized Older Patients
por: Bellanti, Francesco, et al.
Publicado: (2020)

Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient
por: Bellanti, Francesco, et al.
Publicado: (2021)

Redox-Dependent Modulation of Human Liver Progenitor Cell Line Fate
por: Bellanti, Francesco, et al.
Publicado: (2023)

Alteration of circulating redox balance in coronavirus disease-19-induced acute respiratory distress syndrome
por: Bellanti, Francesco, et al.
Publicado: (2023)

Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression
por: Bellanti, Francesco, et al.
Publicado: (2017)

Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach
por: Serviddio, Gaetano, et al.
Publicado: (2016)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Oxidation of Hepatic Carnitine Palmitoyl Transferase-I (CPT-I) Impairs Fatty Acid Beta-Oxidation in Rats Fed a Methionine-Choline Deficient Diet
por: Serviddio, Gaetano, et al.
Publicado: (2011)

Characteristics of gut microbiota in patients with metabolic associated fatty liver disease
por: Yang, Chao, et al.
Publicado: (2023)

Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases
por: Hernández-Ceballos, Winston, et al.
Publicado: (2021)

The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease
por: Park, Grace, et al.
Publicado: (2021)

Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins
por: Bellanti, Francesco, et al.
Publicado: (2015)

The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C
por: Bellanti, F., et al.
Publicado: (2012)

The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
por: Sanduzzi Zamparelli, Marco, et al.
Publicado: (2016)

Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
por: Boursier, Jerome, et al.
Publicado: (2015)

Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
por: Drożdż, Karolina, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, diet and gut microbiota
por: Finelli, Carmine, et al.
Publicado: (2014)

Retraction: Nonalcoholic fatty liver disease, diet and gut microbiota
por: Finelli, Carmine, et al.
Publicado: (2017)

Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases
por: Kim, Han-Na, et al.
Publicado: (2019)

Fatty Liver Disease and Gut Microbiota: A Comprehensive Update
por: Campo, Lyna, et al.
Publicado: (2018)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
por: Zhao, Yuzhen, et al.
Publicado: (2019)

Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease
por: Pan, Xiongfeng, et al.
Publicado: (2021)

Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients
por: Yang, Lidan, et al.
Publicado: (2022)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013)

Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
por: Rebelos, Eleni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vi8vmure1t3nsp48j4k1udeb8b